For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Arius Research, Inc.

USPTO Granted Patents = 33

Forward Citations = 228

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

David S F Young (33 out of 44 patents)

Susan E Hahn (28 out of 38 patents)

Helen P Findlay (18 out of 27 patents)

4. Lisa M Cechetto (8 out of 13 patents)

5. Miyoko Takahashi (6 out of 9 patents)

6. Alison L Ferry (4 out of 4 patents)

7. Daad Sayegh (3 out of 6 patents)

8. Luis A G Da Cruz (3 out of 3 patents)

9. Fortunata McConkey (2 out of 5 patents)

10. Luis A G daCruz (2 out of 3 patents)

11. Shankar Kumar (1 out of 31 patents)

12. Kristian Rogers (1 out of 1 patent)

13. Michelle Kelleher (1 out of 2 patents)

14. Andrea Warner (1 out of 1 patent)

15. Paul Robert Hinton (1 out of 21 patents)

33 patents: Sort by Forward Citations

1. 7488475 - Antibody therapy of tumors (2009-02-10),

2. 7485300 - Cancerous disease modifying antibodies (2009-02-03),

3. 7468254 - Cytotoxicity mediation of cells evidencing surface expression of MCSP (2008-12-23),

4. 7456259 - Cancerous disease modifying antibodies (2008-11-25),

5. 7456258 - Cancerous disease modifying antibodies (2008-11-25),

6. 7456016 - Cancerous disease modifying antibodies (2008-11-25),

7. 7452979 - Cancerous disease modifying antibodies (2008-11-18),

8. 7452978 - Cancerous disease modifying antibodies (2008-11-18),

9. 7442777 - Cytotoxicity mediation of cells evidencing surface expression of CD63 (2008-10-28),

10. 7431923 - Cytotoxicity mediation of cells evidencing surface expression of CD63 (2008-10-07),

11. 7420041 - Cytotoxicity mediation of cells evidencing surface expression of TROP-2 (2008-09-02),

12. 7420040 - Cytotoxicity mediation of cells evidencing surface expression of TROP-2 (2008-09-02),

13. 7420039 - Individualized anti-cancer antibodies (2008-09-02),

14. 7419792 - Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody (2008-09-02),

15. 7411046 - Cancerous disease modifying antibodies (2008-08-12),

Arius Research, Inc. is a leading biotechnology company that specializes in the discovery and development of innovative antibody therapeutics. With a focus on precision medicine, Arius is revolutionizing the treatment of various diseases such as cancer, autoimmune disorders, and viral infections. Through their cutting-edge research, Arius aims to improve patient outcomes by developing targeted therapies that deliver superior efficacy and safety. Visit their website for more information on their groundbreaking advancements in the field of antibody therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

33 Patents

#37 in Toronto

#385 in Canada

#19,553 in the World

Toronto, Canada

Arius Research, Inc.

Forward Citations = 228

15 inventors:

David S F Young (33 out of 44 patents)

Susan E Hahn (28 out of 38 patents)

Helen P Findlay (18 out of 27 patents)

4. Lisa M Cechetto (8 out of 13 patents)

5. Miyoko Takahashi (6 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…